Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of low-dose esketamine on emergence agitation after pediatric tonsillectomy
ChiCTR2100048918Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Emergence agitation (EA) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Adverse event rates within the PACU, Recovery time and 1 more. Started Oct 2021; status: completed.
02
Drugs
esketamine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on ChiCTR2100048918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048918.